Partek Milestone – Cited in Over 3,000 Peer-reviewed Articles

Topics Include Differential Gene Expression, Gene-annotation Enrichment Analysis, and Copy Number Analysis Studies

ST. LOUIS — 2.18.15 — Partek Incorporated has reached a milestone by having its software cited in over three thousand peer-reviewed scientific publications including prestigious publications such as 
New England Journal of Medicine, Cell, and Nature. On average that is about two citations per business day in the last five years on topics including drug research, human genetics and disease relationships, causes, diagnosis, and treatments. Samples of scientific papers citing the use of Partek software are listed on the Partek website.

When asked the reason so many researchers have used Partek software in their publications, Donald Meyer, COO for Partek, pointed to their long history in the genomics field as well as the ease of use of their software. “Partek software has been used in the Life Sciences for more than 15 years. We are proud that we have been able to assist scientists in their studies of disease and treatments.”

“All of us at Partek get a great deal of satisfaction knowing that the software we create is being used by scientists to advance the health and well-being of people worldwide,” said Tom Downey, CEO of Partek.

About Partek Incorporated 

Partek Incorporated ( develops and globally markets quality analysis software for life sciences research and provides innovative solutions for integrated genomics. Partek software is unique in supporting all major microarray and next-generation sequencing platforms. Over three thousand peer-reviewed scientific papers have used our software to streamline analysis of the Gene Expression, miRNA Expression, Copy Number, Allele-Specific Copy Number, LOH, Association, Trio analysis, ChIP-Seq, RNA-Seq, DNA-Seq, DNA Methylation and qPCR studies. Since 1993, Partek, headquartered in St. Louis, MO, USA, has been turning data into discovery®.

Leave a Reply

Your email address will not be published. Required fields are marked *


Time limit is exhausted. Please reload CAPTCHA.